| |
|
|
|
|
|
White solid. HYGROSCOPIC. PACKAGED UNDER INERT GAS. A cell-permeable, short-chained fatty acid that inhibits histone deacetylase (IC50 = 400 µM for HDAC1). Induces differentiation and inhibits proliferation of cell lines derived from human malignant gliomas. At therapeutic levels (350 µM-1.04 mM), causes inositol depletion, inhibits both GSK-3a and -3b, activates ERK pathway and produces neurotropic effects. Has been used as an anti-epileptic agent. Also reported to stimulate peroxisome proliferator-activated receptor (PPAR) activity.
|
Company:
Date:
December 03, 2008
|
|
|
|
|
|
|
|
|
|
Siemens offers a panel of Therapeutic Drug Monitoring (TDM) assays that meet the majority of any laboratory’s high volume TDM testing needs. This broad panel allows the consolidation of a greater number of your high volume TDM assays onto one immunoassay platform. Our TDM assays also deliver excellent performance which gives you confidence in reported results. All run on the most productive and adaptable instruments available ensuring greater throughput and flexibility.
|
Company:
Date:
December 03, 2008
|
|
|
|
|
|
|
|
|
|
DEPAKENE is a carboxylic acid designated as 2-propylpentanoic acid. It is also knwn as dipropylacetic acid.
|
Company:
Date:
December 03, 2008
|
|
|
|
|
|
|
|
|
|
VPA reagent is used to measure the valproic acid concentration by a particle enhanced turbidimetric inhibition immunoassay method.1 Particle-bound drug (PBD) binds to valproic acid specific antibody (Ab) resulting in the formation of insoluble aggregates causing turbidity. Non-particle-bound valproic acid in the patient sample competes with the PBD for the antibody binding sites, inhibiting the formation of insoluble aggregates. The rate and amount of particle aggregation is inversely proportional upon the concentration of valproic acid in the sample.
|
Company:
Date:
December 03, 2008
|
|
|
|
|
|
|
|
|
|
VPA reagent is used to measure the valproic acid concentration by a particle enhanced turbidimetric inhibition immunoassay method.1 Particle-bound drug (PBD) binds to valproic acid specific antibody (Ab) resulting in the formation of insoluble aggregates causing turbidity. Non-particle-bound valproic acid in the patient sample competes with the PBD for the antibody binding sites, inhibiting the formation of insoluble aggregates. The rate and amount of particle aggregation is inversely proportional upon the concentration of valproic acid in the sample.
|
Company:
Date:
December 03, 2008
|
|
|
|
|
|
|
|
|
|
VPA reagent is used to measure the valproic acid concentration by a particle enhanced turbidimetric inhibition immunoassay method.1 Particle-bound drug (PBD) binds to valproic acid specific antibody (Ab) resulting in the formation of insoluble aggregates causing turbidity. Non-particle-bound valproic acid in the patient sample competes with the PBD for the antibody binding sites, inhibiting the formation of insoluble aggregates. The rate and amount of particle aggregation is inversely proportional upon the concentration of valproic acid in the sample.
|
Company:
Date:
December 03, 2008
|
|
|
|
|
|
|
|
|
|
Valproic Acid
|
Company:
Date:
December 03, 2008
|
|
|
|
|
|
|
|
|
|
VPA reagent is used to measure the valproic acid concentration by a particle enhanced turbidimetric inhibition immunoassay method.1 Particle-bound drug (PBD) binds to valproic acid specific antibody (Ab) resulting in the formation of insoluble aggregates causing turbidity. Non-particle-bound valproic acid in the patient sample competes with the PBD for the antibody binding sites, inhibiting the formation of insoluble aggregates. The rate and amount of particle aggregation is inversely proportional upon the concentration of valproic acid in the sample.
|
Company:
Date:
December 03, 2008
|
|
|
|
|
|
|
|
|
|
White solid. HYGROSCOPIC. PACKAGED UNDER INERT GAS. A cell-permeable, short-chained fatty acid that inhibits histone deacetylase (IC50 = 400 µM for HDAC1).
|
Company:
Date:
December 03, 2008
|
|
|
|
|
|
|
|
|
|
DEPAKENE(valproic acid) is a carboxylic acid designated as 2-propylpentanoic acid. It is also knwn as dipropylacetic acid.
|
Company:
Date:
March 03, 2009
|
|
|
|
|